REFINE YOUR SPECIALTY COMMERCIAL STRATEGY TO INCREASE MARKET ACCESS AND SALES
A key area of growth in the current pharma market place stems from the huge commercial potential of specialty drugs. High margins and low entry costs have already enticed big pharma to focus significant resources on specialty business strategies as a key driver in maintaining profitability and growing market share.
Every year, eyeforpharma run the world’s only commercially focused specialty conference to help pharma companies take advantage of the huge opportunities available in the space. Discover how to:
- Increase your specialty sales dramatically with a more effective and profitable commercial strategy
- Get the latest information on changing healthcare reforms and how they’ll affect your specialty business
- Shift the focus of your specialty sales strategy to customer centricity to increase access and market share
- Train and incentivize a high quality, knowledgeable specialty sales force and maximize returns
Key Topics to be discussed include
- Stakeholders: Engage and build relationships with payers, physicians and patient to improve health outcomes and your products success.
- Biosimiliars: Ensure your Biosimiliars’ value proposition meets the needs of payers and illustrates clear patient benefits over competitor products.
- Distribution: Maximize sales with a clear distribution strategy that utilizes key stakeholders throughout the drugs lifecycle.
- Sales: Tailor you sales force to with innovative training and proven incentive compensation schemes.
- Reimbursement: Show clear value-based reimbursement solutions to improve your products chances of success.
Thought provoking, informative, heading in the right direction! 
Linda Mattews, Execution and Delivery Management, Bayer Healthcare
Who will you meet at the event?
94% of the 2010 attendees said they would recommend this event to a colleague or friend
Take a look at some of our exceptional delegates from the 2010 Boston summit, which included top senior-level executives from big and small specialty companies:
- Accorda
- Actelion
- Allergan
- Amgen
|
- Bayer
- Cubist
- Curascript
- Ferring
|
- Genzyme
- GlaxoSmithKline
- Map Pharmaceuticals
|
- Shire
- Vanguard
- Ipsen pharmaceuticals
|
This is an excellent opportunity to learn more about the evolution of Specialty pharma, identify future opportunities and meet colleagues 
Jim McAllister, President, CardeaRX
| Still wondering if this event is for you?? |
It is the only event dedicated exclusively to commercial excellence for specialty pharma
With the end of the blockbuster era, all eyes are on the Specialty industry where the high margins and low market entry costs produce large profits. There is much to learn from smaller, more creative specialty pharma companies who remain successful with a small, multidisciplinary workforce of sales reps.
This summit is your chance to network with both big and small pharma to learn from the essential successful Specialty companies. |
|